Next report date
Report period
H1 2024
EPS estimate
−0.13HKD
Revenue estimate
—
−159.91 MHKD
62.54 MHKD
182.20 M
Om ASCLETIS PHARMA INC
Sektor
Bransch
VD
Jinzi J. Wu
Webbplats
Huvudkvarter
Hangzhou
Employees (FY)
219
Grundat
2013
ISIN
KYG0520K1094
FIGI
BBG00LG50P53
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
